Antibiotics use in patients with COVID-19 in a national hospital in Lima, Perú

Authors

  • Luis Enrique Carrasco-Lozano Universidad Nacional Mayor de San Marcos, Lima, Perú; Hospital Nacional Arzobispo Loayza, Lima, Perú
  • Jorge Hurtado-Alegre Universidad Continental, Huancayo, Perú

DOI:

https://doi.org/10.35434/rcmhnaaa.2023.162.1879

Keywords:

COVID-19, antibiotics, mortality, Peru

Abstract

Objective: To determine the frequency of antibiotic use in patients with COVID-19 in a national hospital in Lima, Peru, as well as their laboratory characteristics and outcomes. Findings: 274 patients were included, with a prevalence of general and early antibiotic therapy of 45.62% and 28.1% respectively, with a mortality of 37.59%. General antibiotic therapy was associated with leukocytosis, left shift, and increased PCR. Early antibiotic therapy was associated with leukocytosis and left shift. The frequency of admission to the ICU was higher in patients with early antibiotic therapy. There was no association between general or early antibiotic therapy with mortality. Conclusions: The frequency of antibiotic use in patients with COVID-19 is high, mainly associated with leukocytosis and left shift; and does not decrease mortality.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Author Biographies

Luis Enrique Carrasco-Lozano, Universidad Nacional Mayor de San Marcos, Lima, Perú; Hospital Nacional Arzobispo Loayza, Lima, Perú

  1. Médico Internista

Jorge Hurtado-Alegre, Universidad Continental, Huancayo, Perú

  1. Médico Infectólogo

References

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-33. DOI: 10.1056/NEJMoa2001017.

Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5(4):536-44. DOI: 10.1038/s41564-020-0695-z.

WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020 [Internet]. [citado el 4 de febrero de 2023]. Disponible en: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020

Sieswerda E, de Boer MGJ, Bonten MMJ, Boersma WG, Jonkers RE, Aleva RM, et al. Recommendations for antibacterial therapy in adults with COVID-19 – an evidence based guideline. Clin Microbiol Infect. 2021;27(1):61-6. DOI: 10.1016/j.cmi.2020.09.041.

Langford BJ, So M, Raybardhan S, Leung V, Soucy J-PR, Westwood D, et al. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect. 2021;27(4):520-31. DOI: 10.1016/j.cmi.2020.12.018.

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-20. DOI: 10.1056/NEJMoa2002032.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054-62. DOI: 10.1016/S0140-6736(20)30566-3.

Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26(12):1622-9. DOI: 10.1016/j.cmi.2020.07.016.

Echevarria-Castro N, Rojo Garcia DA, Torpoco Rivera M, Rondán-Guerrero P, García-Rojas F, Taype-Rondan A. Tendencias en el uso de fármacos para la COVID-19 durante la primera ola de la pandemia en un hospital de Lima, Perú. Rev Peru Med Exp Salud Publica. 2021;38(4). DOI: 10.17843/rpmesp.2021.384.8820.

Cavalcanti-Ramírez S, Moyano LM, León-Jiménez FE. Características de las Infecciones asociadas a atenciones en la salud y uso de antibióticos en una Unidad de Cuidados Intensivos COVID-19, del norte peruano: 2020-2021. Rev. Cuerpo Med. HNAAA [Internet]. 1 de febrero de 2023 [citado el 4 de febrero de 2023];15(4). DOI: 10.35434/rcmhnaaa.2022.154.1786

Center for Disease Control and Prevention. You’ve Been Prescribed an Antibiotic in the Hospital for an Infection. [citado 11 de mayo de 2023]; Disponible en: https://www.cdc.gov/antibiotic-use/community/pdfs/aaw/FS_YouveBeenPrescribed_FINAL508.pdf

Rice TW, Wheeler AP, Bernard GR, Hayden DL, Schoenfeld DA, Ware LB, et al. Comparison of the SpO2/FIO2 ratio and the PaO2/FIO2 ratio in patients with acute lung injury or ARDS. Chest. 2007;132(2):410-7. DOI: 10.1378/chest.07-0617

World Medical Association. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA. 2013;310(20):2191. DOI: 10.1001/jama.2013.281053

1. Kariyawasam RM, Julien DA, Jelinski DC, Larose SL, Rennert-May E, Conly JM, et al. Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019–June 2021). Antimicrob Resist Infect Control. 2022;11:45. DOI: 10.1186/s13756-022-01085-z

Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014;14(1):13. DOI: 10.1186/1471-2334-14-13.

Tiri B, Sensi E, Marsiliani V, Cantarini M, Priante G, Vernelli C, et al. Antimicrobial Stewardship Program, COVID-19, and Infection Control: Spread of Carbapenem-Resistant Klebsiella Pneumoniae Colonization in ICU COVID-19 Patients. What Did Not Work? J Clin Med. 2020;9(9):2744. DOI: 10.3390/jcm9092744

Garcia-Vidal C, Sanjuan G, Moreno-García E, Puerta-Alcalde P, Garcia-Pouton N, Chumbita M, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2021;27(1):83-8. DOI: 10.1016/j.cmi.2020.07.041.

COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines [Internet]. National Institutes of Health; 2021 [citado el 4 de febrero de 2023]. Disponible en: https://www.covid19treatmentguidelines.nih.gov/

World Health Organization. Living guidance for clinical management of COVID-19: living guidance, 23 November 2021 [Internet]. World Health Organization; 2021 [citado el 4 de febrero de 2023]. Disponible en: https://apps.who.int/iris/handle/10665/349321

Beović B, Doušak M, Ferreira-Coimbra J, Nadrah K, Rubulotta F, Belliato M, et al. Antibiotic use in patients with COVID-19: a ‘snapshot’ Infectious Diseases International Research Initiative (ID-IRI) survey. J Antimicrob Chemother. 2020;75(11):3386-90. DOI: 10.1093/jac/dkaa326.

Bastos GAN, de Azambuja AZ, Polanczyk CA, Gräf DD, Zorzo IW, Maccari JG, et al. Clinical characteristics and predictors of mechanical ventilation in patients with COVID-19 hospitalized in Southern Brazil. Rev Bras Ter Intensiva. 2020;32(4):487-92. DOI: 10.5935/0103-507X.20200082.

Mayta-Tristán P. Los tsunamis por Covid-19 en Perú: El primero malo, segundo peor. Rev. Cuerpo Med. HNAAA. 2021;14(3):260-1. DOI: 10.35434/rcmhnaaa.2021.143.1249.

Mejía F, Medina C, Cornejo E, Morello E, Vásquez S, Alave J, et al. Oxygen saturation as a predictor of mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru. PLOS ONE. 2020;15(12):e0244171. DOI: 10.1371/journal.pone.0244171.

Goncalves Mendes Neto A, Lo KB, Wattoo A, Salacup G, Pelayo J, DeJoy R, et al. Bacterial Infections and Patterns of Antibiotic Use in Patients with COVID‐19. J Med Virol. 2021;1489-95. DOI: 10.1002/jmv.26441.

Published

2023-10-12

How to Cite

1.
Carrasco-Lozano LE, Hurtado-Alegre J. Antibiotics use in patients with COVID-19 in a national hospital in Lima, Perú. Rev. Cuerpo Med. HNAAA [Internet]. 2023 Oct. 12 [cited 2024 May 15];16(2). Available from: http://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/1879